John, C., Shen, X., Deng, B., Zhao, Z., Zhou, C., Bae-Jump, V., … Spasojevic, I. (2023). Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer (043). In Gynecologic Oncology (Vol. 176, pp. S37–S38). Elsevier BV. https://doi.org/10.1016/j.ygyno.2023.06.516

John, Catherine, Xiaochang Shen, Boer Deng, Ziyi Zhao, Chunxiao Zhou, Victoria Bae-Jump, Angeles Alvarez Secord, Ines Batinic-Haberle, and Ivan Spasojevic. “Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer (043).” In Gynecologic Oncology, 176:S37–38. Elsevier BV, 2023. https://doi.org/10.1016/j.ygyno.2023.06.516.

John C, Shen X, Deng B, Zhao Z, Zhou C, Bae-Jump V, et al. Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer (043). In: Gynecologic Oncology. Elsevier BV; 2023. p. S37–8.

John, Catherine, et al. “Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer (043).” Gynecologic Oncology, vol. 176, Elsevier BV, 2023, pp. S37–38. Crossref, doi:10.1016/j.ygyno.2023.06.516.

John C, Shen X, Deng B, Zhao Z, Zhou C, Bae-Jump V, Secord AA, Batinic-Haberle I, Spasojevic I. Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer (043). Gynecologic Oncology. Elsevier BV; 2023. p. S37–S38.